CP Cannon
CP Cannon publishes mostly in Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism and Pharmacology, on topics such as Diabetes Treatment and Management, Acute Myocardial Infarction Research and Metabolism, Diabetes, and Cancer.
- World rank
- #6,362,517 of 7,710,434 ranked researchers
- Rank in Germany
- #321,699 of 364,343
- Works
- 21
- Citations
- 107
- Citations per work
- 5.1
What does CP Cannon research?
CP Cannon's work is mostly in Medicine (56%), Biochemistry, Genetics and Molecular Biology (6%), Economics, Econometrics and Finance (6%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences1256.3%
- Medicine1256.3%
- Everything else731.1%
- Life Sciences16.3%
- Social Sciences16.3%
- 1Cardiology and Cardiovascular Medicine25% of their works
- 2Endocrinology, Diabetes and Metabolism17% of their works
- 3Pharmacology8% of their works
- 4Internal Medicine6% of their works
- 5Economics and Econometrics6% of their works
- 6Molecular Biology6% of their works
Research topics
- Diabetes Treatment and Management
- Acute Myocardial Infarction Research
- Metabolism, Diabetes, and Cancer
- Venous Thromboembolism Diagnosis and Management
- Health Systems, Economic Evaluations, Quality of Life
- Antiplatelet Therapy and Cardiovascular Diseases
- Diabetes Management and Research
- Acute Ischemic Stroke Management
Which keywords describe CP Cannon's research?
The keywords of their largest research topics: Glycemic Control, Insulin Therapy, Cardiovascular Disease, Cardiovascular Outcomes, Type 2 Diabetes, Acute Coronary Syndromes, Myocardial Infarction and Risk Factors.
- Thrombolysis
- Hypoglycemia
- Clopidogrel
- Venous Thromboembolism
- Metformin
- Antithrombotic Therapy
- Risk Factors
- Acute Coronary Syndromes
- Cardiovascular Outcomes
- Insulin Therapy
- Glycemic Control
- Cardiovascular Disease
- Type 2 Diabetes
- Myocardial Infarction
- AMP-Activated Protein Kinase
- Cost-effectiveness Analysis
- Quality of Life
- Aspirin
- Diabetes
- Ischemic Stroke
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 20 words, with their numbers
- Glycemic Control82 topics
- Insulin Therapy82 topics
- Cardiovascular Disease72 topics
- Cardiovascular Outcomes61 topic
- Type 2 Diabetes61 topic
- Acute Coronary Syndromes51 topic
- Myocardial Infarction51 topic
- Risk Factors52 topics
- AMP-Activated Protein Kinase31 topic
- Antithrombotic Therapy31 topic
- Cost-effectiveness Analysis31 topic
- Metformin31 topic
- Quality of Life31 topic
- Venous Thromboembolism31 topic
- Aspirin21 topic
- Clopidogrel21 topic
- Diabetes21 topic
- Hypoglycemia21 topic
- Ischemic Stroke21 topic
- Thrombolysis21 topic
Where does CP Cannon work?
CP Cannon's main affiliation in the publication record is Boehringer Ingelheim (Germany), Germany.
How many publications and citations does CP Cannon have?
OpenAlex counts 21 works and 107 citations for CP Cannon, an h-index of 5, ranking #6,362,517 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about CP Cannon. Posts are plain text and can be reported.